Literature DB >> 19247625

[Semi-implantable hearing aids for sensorineural hearing loss and combined hearing loss: experiences at the German Armed Forces Hospital in Ulm].

M Tisch1, H Maier.   

Abstract

In recent years semi-implantable hearing aids have become an established option in the treatment of sensorineural hearing loss. In Germany two semi-implantable systems are available, namely the MedEl Soundbridge system and the Otologics MET system, both of which are active middle ear implants. Since 1996 almost 3,500 Soundbridge systems and 300 MET systems have been implanted world-wide. The majority of patients who have received semi-implantable hearing aids consider them to be superior to conventional hearing aids in many respects. Reported benefits include improved speech intelligibility (especially in noise), better sound quality, a more natural sounding own voice and the general advantages of an open ear canal. Implantable hearing systems can be used for a wider range of indications than conventional hearing aids. They are particularly useful in the treatment of patients with high-frequency hearing loss and patients with combined hearing loss. An analysis of the hearing outcomes that have thus far been reported for all patients with a hearing implant shows an average improvement in the hearing threshold by 15 dB, which corresponds to an improvement in hearing of more than 30%. As a consequence semi-implantable hearing systems are an excellent addition to the existing range of conventional hearing aids.

Entities:  

Mesh:

Year:  2009        PMID: 19247625     DOI: 10.1007/s00106-008-1851-6

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  44 in total

1.  First audiometric results with the Vibrant soundbridge, a semi-implantable hearing device for sensorineural hearing loss.

Authors:  A F Snik; C W Cremers
Journal:  Audiology       Date:  1999 Nov-Dec

2.  The Otologics MET ossicular stimulator.

Authors:  J F Kasic; J M Fredrickson
Journal:  Otolaryngol Clin North Am       Date:  2001-04       Impact factor: 3.346

3.  Gain and maximum output of two electromagnetic middle ear implants: are real ear measurements helpful?

Authors:  Ad Snik; John Noten; Cor Cremers
Journal:  J Am Acad Audiol       Date:  2004-03       Impact factor: 1.664

4.  Minimally invasive approach and fixation of cochlear and middle ear implants.

Authors:  D Jiang; A Bibas; A Fitzgerald O'Connor
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-12

5.  The effects of mass loading the ossicles with a floating mass transducer on middle ear transfer function.

Authors:  A J Needham; D Jiang; A Bibas; G Jeronimidis; A Fitzgerald O'Connor
Journal:  Otol Neurotol       Date:  2005-03       Impact factor: 2.311

6.  Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window.

Authors:  Vittorio Colletti; Sigfrid D Soli; Marco Carner; L Colletti
Journal:  Int J Audiol       Date:  2006-10       Impact factor: 2.117

7.  A multicenter study of the Vibrant Soundbridge middle ear implant: early clinical results and experience.

Authors:  B Fraysse; J P Lavieille; S Schmerber; V Enée; E Truy; C Vincent; F M Vaneecloo; O Sterkers
Journal:  Otol Neurotol       Date:  2001-11       Impact factor: 2.311

8.  Functional gain of already implanted hearing devices in patients with sensorineural hearing loss of varied origin and extent: Berlin experience.

Authors:  Rüdiger Junker; Manfred Gross; Ingo Todt; Arne Ernst
Journal:  Otol Neurotol       Date:  2002-07       Impact factor: 2.311

9.  Otologics Middle Ear Transducer Ossicular Stimulator: performance results with varying degrees of sensorineural hearing loss.

Authors:  Herman A Jenkins; John K Niparko; William H Slattery; J Gail Neely; John M Fredrickson
Journal:  Acta Otolaryngol       Date:  2004-05       Impact factor: 1.494

10.  U.S. Phase I preliminary results of use of the Otologics MET Fully-Implantable Ossicular Stimulator.

Authors:  Herman A Jenkins; James S Atkins; Drew Horlbeck; Michael E Hoffer; Ben Balough; Joseph V Arigo; George Alexiades; William Garvis
Journal:  Otolaryngol Head Neck Surg       Date:  2007-08       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.